Long-term safety of pegloticase in chronic gout refractory to conventional treatment

2011 Recommendations for the Diagnosis and Management of Gout and Hyperuricemia

(2012) Max Hamburger et al.   POSTGRADUATE MEDICINE

Prevalence of gout and hyperuricemia in the US general population: The National Health and Nutrition Examination Survey 2007-2008

(2011) Yanyan Zhu et al.   ARTHRITIS AND RHEUMATISM

Efficacy and Tolerability of Pegloticase for the Treatment of Chronic Gout in Patients Refractory to Conventional Treatment

(2011)   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Managing Gout in the Primary Care Setting: What You and Your Patients Need to Know

(2010) Paul P. Doghramji et al.   AMERICAN JOURNAL OF MEDICINE

Chronic gout: epidemiology, disease progression, treatment and disease burden

(2010) Richard A. Brook et al.   CURRENT MEDICAL RESEARCH AND OPINION

Pegloticase

(2010) Naomi Schlesinger et al.   NATURE REVIEWS DRUG DISCOVERY

Clinical Efficacy and Safety of Successful Longterm Urate Lowering with Febuxostat or Allopurinol in Subjects with Gout

(2009) M. A. BECKER et al.   JOURNAL OF RHEUMATOLOGY

Gout

(2009) Pascal Richette et al.   LANCET

Treatment-failure gout: A moving target

(2008) N. Lawrence Edwards   ARTHRITIS AND RHEUMATISM

PEG-uricase in the management of treatment-resistant gout and hyperuricemia

(2007) Merry R. Sherman et al.   ADVANCED DRUG DELIVERY REVIEWS